A-Rod’s lawyer, Joe Tacopina, went on ESPN radio yesterday and reminded people that his client is not the first one to be linked to PEDs:
Of course this is a reference to David Ortiz.
A lot of people are trying to make this comment out as uber-controversial or a “shots fired” moment or something, but that seems silly to me. It’s been nearly five years since Ortiz was reported by the New York Times to have tested positive for PEDs during the 2003 survey testing. He claimed surprise and innocence at the time and made noises about wanting to get down to the bottom of it all, but we never really did get down to the bottom of it.
I have no idea what caused David Ortiz to test positive in 2003, but (a) the union has a list of all of the people who tested positive on that survey testing and if he were wrongfully reported to be on it, they would have corrected it years ago; and (b) regardless, no excuses or explanations like the one Ortiz gave has ever been accepted at face value by the sporting press or most fans. So for anyone to claim now that accusing Ortiz of PED use is somehow controversial or out of bounds is ridiculous. It’s about wanting to slam A-Rod and Tacopina, not about actually being offended at such an allegedly provocative comment.
And, of course, there is a lot of truth to what Tacopina was getting at. While his client is and perhaps always will be a pariah, a lot of guys with PED use in their past are not, and it’s rarely if ever about drugs they took as opposed to whether they were well-liked before or whether they had the nerve to try to defend themselves in a strenuous way.
People like David Ortiz and Andy Pettitte. People hate A-Rod and Barry Bonds and Roger Clemens. I totally understand why and don’t begrudge those differences of opinion at all. But let’s not pretend that Tacopina said something shocking yesterday.
You might want to sit down for this news. Giants manager Bruce Bochy has tabbed ace Madison Bumgarner to start on Opening Day in Milwaukee against the Brewers, CSN Bay Area’s Alex Pavlovic reports. Shocking, I know.
The Giants had a busy offseason, adding Johnny Cueto and Jeff Samardzija to the starting rotation, but neither had a shot at getting the Opening Day nod considering what Bumgarner has done for the Giants over the last five seasons.
Since the start of the 2011 season, the 26-year-old lefty compiled a 3.05 ERA with 1,034 strikeouts and 239 walks across 1,050 innings. Among starters who logged at least 800 innings in that span of time, only Clayton Kershaw, Cueto, Zack Greinke, David Price, and Felix Hernandez have posted lower ERAs. And Bumgarner is the only one among them with a championship ring. In fact, he has three.
We’re almost halfway through February. Pitchers and catchers report to spring training soon. And yet, there are more than a handful of solid free agents that remain unsigned. Among them: Yovani Gallardo, Ian Desmond, and Dexter Fowler. All three have draft pick compensation tied to them, as each rejected a one-year, $15.8 million qualifying offer from his respective former team. That, undoubtedly, is a reason why they haven’t inked a contract yet.
MLBPA Executive Director Tony Clark is unhappy about this reality and expects to discuss potential changes when the next collective bargaining agreement is negotiated. The current CBA expires after the 2016 season. Per the Associated Press, Clark said last week, “I think it’s disappointing when there are as many talented players still without a home. I don’t think it’s in anyone’s best interest to be in a world where very talented players are at home for whatever reason they are there. It will likely be a part of the conversation in bargaining.”
Clark also mentioned, among other things, the possibility of a draft lottery, which would take away the incentive for teams to “tank”, or lose on purpose. The Astros and Phillies have notably done this in recent years, finishing with baseball’s worst record and thus netting the #1 overall draft pick.
These are, however, simply two items of many that will be discussed during the upcoming offseason. It will be interesting to see what solutions are eventually put in place.
It was reported on Friday that Yankees right-hander Masahiro Tanaka isn’t sure if he’ll be ready for Opening Day as he makes his way back from arthroscopic surgery to remove a bone spur from his right elbow. His health will be crucial to the Yankees’ chances this season, but the same goes for rotation-mate Michael Pineda, who hopes that this is the year he’ll be able to take on the workload of a frontline starter.
Pineda was on pace for a career-high in innings last season, but he landed on the disabled list in late July with a right flexor forearm muscle strain and missed a month. He struggled upon his return and ended up with 160 2/3 innings, so he fell short of his career-high of 171 innings as a rookie with the Mariners way back in 2011. Now going into his age-27 season, Pineda told Bryan Hoch of MLB.com that his goal for 2016 is to reach 200 innings for the first time in his career.
“For me, this year, I’m coming here early to be strong and working hard to pitch 200 innings this year,” Pineda said at the club’s Minor League complex. “I want to throw 200 innings this year. This is my goal, and help my team.”
Pineda had a mediocre 4.37 ERA (90 ERA+) last season despite impressive peripherals with 8.7 K/9 and 1.2 BB/9. Among pitchers with at least 160 innings pitched, only Bartolo Colon of the Mets had a lower walk percentage. Pineda managed to increase his ground ball rate to 48.2 percent and also saw an uptick in velocity from 2014, so there’s reason to believe in improvement if he can stay healthy.
The Brewers acquired prospects Jake Nottingham and Bubba Derby from the Athletics on Friday in exchange for slugging outfielder Khris Davis. The hope is that Nottingham will develop into the Brewers’ catcher of the future, so you could say that the club is planning for life after Jonathan Lucroy. However, Brewers general manager David Stearns said today that the trade doesn’t change Lucroy’s immediate status.
The Brewers are in rebuild-mode and Lucroy is an excellent trade chip if healthy, as his contract includes a $5.25 million club option for 2017. It’s likely just a matter of time before he’s shipped elsewhere, but yesterday’s trade shouldn’t change the timeline for a potential deal. Nottingham doesn’t turn 21 until April and has yet to play in Double-A, so he’s still a ways off from the majors. The Brewers can afford to wait on the right offer for Lucroy, whether it’s in spring training or at the trade deadline or perhaps later.
Checking in at 6-foot-3 and 230 pounds, Nottingham batted .316/.372/.505 with 17 home runs over 109 games last season between Class A and High-A. He was traded from the Astros to the Athletics as part of the Scott Kazmir deal last July. It’s worth noting that Stearns was the assistant GM for Houston when Nottingham was drafted in the sixth round back in 2013, so he’s clearly a fan.